Results 11 to 20 of about 234,795 (273)

Infliximab for the treatment of plaque psoriasis

Biologics: Targets & Therapy, 2008
Jennifer S Gall, Robert E KalbState University of New York at Buffalo, School of Medicine and Biomedical Sciences, Department of Dermatology, NY, USAAbstract: Infliximab is a monoclonal antibody that targets tumor necrosis factor-α (TNF& ...
Jennifer S Gall, Robert E Kalb
doaj   +5 more sources

Etanercept in the treatment of plaque psoriasis [PDF]

Clinical, Cosmetic and Investigational Dermatology, 2009
Etanercept is approved for the treatment of moderate to severe plaque psoriasis at a dose of 50 mg twice weekly for 3 months followed by a maintenance dosage of 50 mg weekly thereafter. Clinical studies have shown excellent efficacy, favorable benefit to side-effects ratio, and safe long-term usage.
John Koo, null Nguyen, John Koo
openaire   +5 more sources

Chronic Plaque Psoriasis [PDF]

South African Family Practice, 2006
Chronic plaque psoriasis, the most common form of psoriasis, is a papulosquamous disease defined by erythematous plaques with a silvery scale. The diagnosis usually is clinical, but occasionally a biopsy is necessary. Psoriasis affects 0.6 to 4.8 percent of the U.S. population, and about 30 percent of affected patients have a first-degree relative with
Luba, KM, Stulberg, DL
core   +5 more sources

Infliximab in the treatment of plaque type psoriasis

Clinical, Cosmetic and Investigational Dermatology, 2009
Rosita Saraceno, Andrea Saggini, Lucia Pietroleonardo, Sergio ChimentiDepartment of Dermatology, University of Rome Tor Vergata, Rome, Viale Oxford 81, Rome, ItalyAbstract: Psoriasis is a chronic and immunomediated skin disease characterized by ...
Rosita Saraceno, Andrea Saggini, Lucia Pietroleonardo, Sergio Chimenti   +3 more
doaj   +1 more source

The Effect of Weight Loss in Obese Patients with Chronic Stable Plaque-Type Psoriasis [PDF]

Dermatology Research and Practice, 2013
Background. Chronic plaque psoriasis is frequently associated with obesity. The effect of a low-calorie diet on psoriasis has not been investigated. Objective.
Wanjarus Roongpisuthipong, Marinya Pongpudpunth, Chulaporn Roongpisuthipong, Natta Rajatanavin   +3 more
doaj   +2 more sources

Highlighting Interleukin-36 Signalling in Plaque Psoriasis and Pustular Psoriasis

Acta Dermato-Venereologica, 2017
Plaque psoriasis and pustular psoriasis are overlapping, but distinct, disorders. The therapeutic response to biologics supports the pivotal role of the tumour necrosis alpha (TNF-?)/ interleukin (IL)-23/IL-17/IL-22 axis in the pathogenesis of these ...
Kazuhisa Furue, Kazuhiko Yamamura, Gaku Tsuji, Chikage Mitoma, Hiroshi Uchi, Takeshi Nakahara, Makiko Kido-Nakahara, Takafumi Kadono, Masutaka Furue   +8 more
doaj   +2 more sources

Basic Therapeutic Approach for Patients with Plaque Psoriasis: Korean Expert Consensus Using the Modified Delphi Method [PDF]

, 2023
Background: Currently, there is no consensus on the treatment of psoriasis in Korean patients. Objective: This study aimed to establish a consensus on the basic therapeutic principles for Korean patients with plaque psoriasis.
김태균, Jo, SJ, Baek, YS, Choe, Yong Beom, Kim, B, Eun-So Lee, Yong Beom Choe, Lee, Eun-So, Choi, YS, Kim, Jeong Eun, Tae-Gyun Kim, Byungsoo Kim, Seong Jin Jo, Jeong Eun Kim, Lee, ES, Jeong, KH, Choe, YB, Kim, Tae-Gyun, Jeong, Ki-Heon, Jo, Seong Jin, Kim, TG, Yu Sung Choi, Korean Society for Psoriasis, Kim, JE, Kim, Byungsoo, Choi, Yu Sung, Ki-Heon Jeong, Yoo Sang Baek, Baek, Yoo Sang   +28 more
core   +1 more source

The Sense of Stigmatization in Patients with Plaque Psoriasis [PDF]

Dermatology, 2020
<b><i>Background:</i></b> Psoriasis is a systemic inflammatory disease capable of creating stigmatization in the form of social exclusion and decrement of psychological conditions. <b><i>Aim:</i></b> The aim of the study was to determine the level of stigmatization in patients with plaque psoriasis. <b&
Barbara Jankowiak, Beata Kowalewska, Elżbieta Krajewska-Kułak, Krystyna Kowalczuk, Dzmitry F. Khvorik   +4 more
openaire   +2 more sources

Manifestation of palmoplantar pustulosis during or after infliximab therapy for plaque-type psoriasis : report on five cases [PDF]

, 2008
Infliximab is a monoclonal antibody directed against TNF-alpha. It has been approved for use in rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, psoriatic arthritis and plaque-type psoriasis.
Krüger, Ullrich, Thaçi, Diamant, Pätzold, Sylvie, Reich, Kristian, Bertsch, Hans Peter, Mössner, Rotraut, Mohr, Johannes, Johannes Mohr, Rotraut Mössner, Diamant Thaci, Ullrich Krüger, Sylvie Pätzold, Hans Peter Bertsch, Kristian Reich   +13 more
core   +1 more source

Coronary Plaque Characterization in Psoriasis [PDF]

Circulation, 2017
Article, see p 263 Psoriasis is a chronic immune-mediated disease that affects both the skin and joints in 30% to 35% of patients.1 Clinically, it is characterized by well-demarcated, erythematous plaques covered by silvery-white scales, traditionally affecting the elbows, knees, and scalp.
Dario, Kivelevitch, Jeffrey M, Schussler, Alan, Menter   +2 more
openaire   +2 more sources